Risk Factors and Secondary Prevention in Women with Heart Disease
Authors: Michael G. Shlipak, Eric Vittinghoff, Stephen Hulley
Journal: Annals of Internal Medicine (2003)

Letters2 December 2003Risk Factors and Secondary Prevention in Women with Heart DiseaseMichael G. Shlipak, MD, MPH, Eric Vittinghoff, PhD, and Stephen Hulley, MD, MPHMichael G. Shlipak, MD, MPHFrom Veterans Affairs Medical Center, San Francisco, CA 94121; and University of California, San Francisco, San Francisco, CA 94115.Search for more papers by this author, Eric Vittinghoff, PhDFrom Veterans Affairs Medical Center, San Francisco, CA 94121; and University of California, San Francisco, San Francisco, CA 94115.Search for more papers by this author, and Stephen Hulley, MD, MPHFrom Veterans Affairs Medical Center, San Francisco, CA 94121; and University of California, San Francisco, San Francisco, CA 94115.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-139-11-200312020-00017 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We appreciate the concerns of Mr. Rathore and Dr. Krumholz and acknowledge that our study had certain limitations. One of these, as we noted, was the absence of the type of information on contraindications to each therapy that had been provided in the Cooperative Cardiovascular Project (CCP) (1). However, our study had the strength of evaluating stable outpatients with coronary heart disease (CHD) and recording medication use at 4-month intervals throughout a 4-year follow-up period. In contrast, the CCP evaluated outpatient therapy only at the time of hospital discharge for MI.Rathore and Krumholz suggest that a substantial ...References1. Marciniak TA, Ellerbeck EF, Radford MJ, Kresowik TF, Gold JA, Krumholz HM, . Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351-7. [PMID: 9582042] CrossrefMedlineGoogle Scholar2. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ. 1998;317:713-20. [PMID: 9732338] CrossrefMedlineGoogle Scholar3. Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, . Health and economic benefits of increased -blocker use following myocardial infarction. JAMA. 2000;284:2748-54. [PMID: 11105180] CrossrefMedlineGoogle Scholar4. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of -blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623-9. [PMID: 9718054] CrossrefMedlineGoogle Scholar5. McCormick D, Gurwitz JH, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Use of aspirin, -blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention? Arch Intern Med. 1999;159:561-7. [PMID: 10090112] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Michael G. Shlipak, MD, MPH; Eric Vittinghoff, PhD; Stephen Hulley, MD, MPHAffiliations: From Veterans Affairs Medical Center, San Francisco, CA 94121; and University of California, San Francisco, San Francisco, CA 94115. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRisk Factors and Secondary Prevention in Women with Heart Disease: The Heart and Estrogen/progestin Replacement Study Eric Vittinghoff , Michael G. Shlipak , Paul D. Varosy , Curt D. Furberg , Christine C. Ireland , Steven S. Khan , Roger Blumenthal , Elizabeth Barrett-Connor , and Stephen Hulley , for the Heart and Estrogen/progestin Replacement Study Research GroupRisk Factors and Secondary Prevention in Women with Heart Disease Saif S. Rathore and Harlan M. Krumholz Metrics 2 December 2003Volume 139, Issue 11Page: 954-955KeywordsCardiovascular therapyCongenital heart diseaseElderlyHealth care providersHeart failureLongitudinal studiesLow density lipoproteinMedical risk factorsOutpatient clinicsOutpatients ePublished: 2 December 2003 Issue Published: 2 December 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...